Why the study?
Does losartan improve renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy?
Does losartan improve renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy?
Losartan provides significant renal benefits and is well tolerated in patients with type 2 diabetes and nephropathy.
Supports losartan for renoprotection in type 2 diabetes with nephropathy; confirms ARB renal benefits in randomized evidence.
Losartan conferred significant renal benefits in patients with type 2 diabetes and nephropathy, and it was generally well tolerated.
No takes yet. Share an insight, caveat, or question.
Brenner et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: